Chiron's Earnings Ills
565236
Flu vaccine manufacturer expected to report significantly lower profits.
595967
BOSTON (CBS.MW) -- Shares of embattled vaccine maker Chiron Corp. slipped notably Wednesday after it announced that UK regulatory authorities had extended a suspension on the company&#39;s license to manufacture at its primary flu vaccine-making facility.
264090
NEW YORK - As Wall Street sifts through more than 300 third-quarter earnings reports this week, technology and pharmaceutical stocks will be getting some of the closest scrutiny.    The focus on drug companies results from a recent spate of bad news about Merck & Co...
61771
EMERYVILLE, Calif. A high-tech executive appointed to Chiron&#39;s board of directors last month has resigned from the embattled biotechnology company.
519784
Chiron Corp. shares plunged more than 16 percent Tuesday after it said the entire stockpile of flu vaccine it made overseas for the U.S. market will be withheld this winter because British authorities suspended ...
99249
Standard &amp; Poor&#39;s on Tuesday said it may cut Chrion Corp.&#39;s (CHIR.O: Quote, Profile, Research) debt ratings, after the company said it will not sell flu vaccine for the coming flu season due to problems at its plant in British.
642544
Still gasping fromÂ the resignation of its chief executiveÂ in January andÂ an ongoing investigation of its accounting practices, Dell reported fourth quarter profits of $673 million, down sharply from the $1 billion it reported for the same period last year.
67567
Chiron (CHIR:Nasdaq - news - research) said Thursday that it had found some problems with the production of its Fluvirin influenza virus vaccine, which will cause a delay in the product&#39;s reaching the market until early October.
383065
Earnings woes, an SEC probe, and a scuffle with Disney spell trouble.
551540
YESTERDAY Close $45.95 Change -$0.51 52-WEEK High $51.50 Low $33.73 The medical research and services company Charles River Laboratories International Inc. of Wilmington said fourth-quarter profit dropped 30 percent due in large part to a year-ago provision for income taxes.
616381
Chiron, the biotech company, has become the subject of a federal grand jury investigation in the US after British regulators last week issued a surprise suspension on the
229447
Chiron Corp.âs aggressive plan to dominate the US flu vaccine market is in tatters and the companyâs financial future is clouded as the public health crisis it caused continues to mount.
301378
The nation&#39;s supply of vaccine for the impending flu season took a big hit Thursday when Chiron Corp. announced it had found tainted doses in its factory.
230074
YESTERDAY Close $17.72 Change -$0.31 52-WEEK High $18.53 Low $11.50 Teradyne Inc.'s second-quarter net income dropped 66 percent to $27.7 million, or 14 cents a share, from $82.4 million, or 40 cents a share, a year earlier.
96722
The suspension of Chiron's flu vaccine has not only cost it three-quarters in expected profits, but also some credibility.
631266
The electronics company warns on third-quarter earnings.
555758
This year&#39;s unexpected shortage of flu vaccine was a result of vaccine doses becoming contaminated during production. On October 5th, Chiron Corporation, a California-based biotechnology